Matches in Wikidata for { <http://www.wikidata.org/entity/Q95324566> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q95324566 description "article scientifique publié en 2020" @default.
- Q95324566 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95324566 description "scientific article published on 20 May 2020" @default.
- Q95324566 description "wetenschappelijk artikel" @default.
- Q95324566 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95324566 name "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 name "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 type Item @default.
- Q95324566 label "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 label "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 prefLabel "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 prefLabel "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 P1433 Q95324566-F45A2EAB-FB16-41DA-BA74-D69AB0D04F99 @default.
- Q95324566 P1476 Q95324566-1F9B35DC-3ECA-4510-AC4E-1C8B1BEFB66F @default.
- Q95324566 P2093 Q95324566-1BC937BF-0471-4B74-8D13-3FED6C39345B @default.
- Q95324566 P2093 Q95324566-27F000B3-2F6A-4A55-9FD1-9EC50EC5683E @default.
- Q95324566 P2093 Q95324566-474E7BF2-CEEE-4C2D-AF16-0C6291E92BFD @default.
- Q95324566 P2093 Q95324566-66A2AFCE-6595-43A0-830C-31D64462C07E @default.
- Q95324566 P2093 Q95324566-8230872F-DA7E-4286-A408-35D91887EB94 @default.
- Q95324566 P2093 Q95324566-D86A1D9C-F938-4D4C-B167-CC41CB13137E @default.
- Q95324566 P2093 Q95324566-E842C308-6004-403C-A33D-EEF2CBB5F581 @default.
- Q95324566 P31 Q95324566-0350914C-6506-45DC-974C-0419B5CE20F1 @default.
- Q95324566 P356 Q95324566-0CF7611F-4616-476C-89D2-C389F097017C @default.
- Q95324566 P577 Q95324566-D911D51F-96F2-4FFB-B027-26CC96F4F2FE @default.
- Q95324566 P698 Q95324566-6633CDEA-AD15-49B3-888F-10D704DC1FDF @default.
- Q95324566 P921 Q95324566-39AC43E3-8965-4B9A-BAAC-F5CBBB855F73 @default.
- Q95324566 P921 Q95324566-FDE09AC5-5C21-45F7-8D76-3E58E82FFBB0 @default.
- Q95324566 P356 ACS.MOLPHARMACEUT.0C00337 @default.
- Q95324566 P698 32433886 @default.
- Q95324566 P1433 Q3011140 @default.
- Q95324566 P1476 "Bilirubin nanomedicines for the treatment of reactive oxygen species (ROS)-mediated diseases" @default.
- Q95324566 P2093 "Caifang Gao" @default.
- Q95324566 P2093 "Chi Teng Vong" @default.
- Q95324566 P2093 "Shengpeng Wang" @default.
- Q95324566 P2093 "Shiyun Chen" @default.
- Q95324566 P2093 "Xu Wu" @default.
- Q95324566 P2093 "Yitao Wang" @default.
- Q95324566 P2093 "Zhejie Chen" @default.
- Q95324566 P31 Q13442814 @default.
- Q95324566 P356 "10.1021/ACS.MOLPHARMACEUT.0C00337" @default.
- Q95324566 P577 "2020-05-20T00:00:00Z" @default.
- Q95324566 P698 "32433886" @default.
- Q95324566 P921 Q261659 @default.
- Q95324566 P921 Q424361 @default.